Defense Sector Accelerates Deployment of Counter-Drone Systems
AI Analysis
The counter-UAS market is rapidly expanding, projected to reach over $20 billion by 2030. ZenaTech is establishing a production base in Ukraine for cost-effective counter-drone systems, while VisionWave is expanding its market reach in public safety. Technological advancements in counter-drone systems include layered defense strategies using kinetic and non-kinetic methods.
Key Takeaways
- Global counter-UAS market projected to exceed $20 billion by 2030.
- ZenaTech setting up production in Ukraine for Interceptor P-1 drones.
- Counter-drone systems use layered defense strategies with kinetic and non-kinetic methods.
- VisionWave expands into Latin American public safety market.
- Technological innovations enhance operational capabilities against drone swarms.
Why It Matters
The rapid growth of the counter-UAS market underscores the increasing threat posed by drones and the necessity for advanced airspace security measures. ZenaTech's strategic move to produce affordable counter-drone systems in Ukraine aims to meet rising demand from U.S. and Gulf defense sectors, while VisionWave's expansion highlights the broader application of drone technology in public safety.
Loading...
Defense Sector Accelerates Deployment of Counter-Drone Systems | Intellectia.AI
Loading... Defense Sector Accelerates Deployment of Counter-Drone Systems | Intellectia.AI menu Intellectia LogoIntellectia Search Get Started
Defense Sector Accelerates Deployment of Counter-Drone Systems
Written by Emily J. Thompson, Senior Investment Analyst Source: Newsfilter Updated: 12 hours ago 0mins
ZENA logo ZENA+9.8% VWAV logo VWAV0% DPRO logo DPRO+10.66% Should l Buy ZENA? Source: Newsfilter
- Surging Market Demand: The global counter-UAS market is projected to grow from $6-8 billion in the mid-2020s to over $20 billion by 2030, with some estimates suggesting it could approach $28 billion by 2032, highlighting the urgent need for airspace security.
- Establishing in Ukraine: ZenaTech is setting up a production base in Ukraine for counter-drone interceptor systems, targeting to produce the Interceptor P-1 drone at under $5,000 each, aiming to accelerate delivery to U.S. and Gulf defense customers.
- Technological Innovation: Counter-drone systems employ a layered defense strategy, incorporating both kinetic and non-kinetic methods such as signal jamming and laser technology, ensuring effective responses against coordinated drone swarms and enhancing operational capabilities on modern battlefields.
- Industry Collaboration: VisionWave has signed a purchase order with a Latin American public safety organization, indicating the expanding application of drone technology in public safety, further driving overall industry growth and technological advancements.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZENA?" and start using high-conviction signals backed by rigorous historical data. Sign up today to access powerful investing tools and make smarter, data-driven decisions. Sign up 1D5D1M3M6MYTD1Y5Y Custom 1DTime Range SelectorCustom LineCandle
Analyst Views on ZENA
Wall Street analysts forecast ZENA stock price to rise 1 Analyst Rating Wall Street analysts forecast ZENA stock price to rise 1 Buy 0 Hold 0 Sell Moderate Buy Current: 2.040 sliders Low 7.00 Averages 7.00 High 7.00 Current: 2.040 sliders Low 7.00 Averages 7.00 High 7.00 Citi Buy maintain $46 2025-12-22 Reason Citi Price Target $46 AI Analysis 2025-12-22 maintain Buy Reason Citi added an "upside 90-day catalyst watch" on shares of Zenas BioPharma while keeping a Buy rating on the shares with a $46 price target ahead of the early January Phase 3 INDIGO readout in immunoglobulin G4-related disease. Citi believes obexlimab is positioned to show a statistically significant reduction in flares relative to placebo. Maxim NULL -> Buy initiated $9 2025-06-17 Reason Maxim Price Target $9 2025-06-17 initiated NULL -> Buy Reason